Patents by Inventor Gary Koppel
Gary Koppel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 4180507Abstract: 1-[.alpha.-(Carboxy)-4-hydroxybenzyl]-3.beta.-aminoazetidin-2-one esters are prepared by converting 2-acyl-3,3-dialkyl-7-oxo-.alpha.-[4-(benzyloxy)phenyl]-4-thia-2,6-diazabic yclo[3.2.0]-heptane-6-acetic acid esters with mercuric acetate in an aqueous organic solvent mixture, e.g., in aqueous methanol, to 7-oxo-3-phenyl-.alpha.-[4-benzyloxy)phenyl]-4-oxa-2,6-diazabicyclo[3.2.0]h ept-2-ene-1-acetic acid esters and the latter are reacted with PCl.sub.5 and pyridine to provide the monocyclic 1-[.alpha.-(carboxy)-4-benzyloxybenzyl]-3.beta.-(.alpha.-chlorobenzylidene amino)-4-chloroazetidin-2-one esters. Reduction of the dichloro azetidin-2-one with an organo tin hydride and azobisisobutyronitrile affords the deschloro, 1-[.alpha.-(carboxy)-4-benzyloxybenzyl]-3.beta.-benzylideneaminoazetidin-2 -one ester. The latter is hydrolyzed and the 4-benzyloxy group is cleaved via catalytic hydrogenolysis to yield an ester of 1-[.alpha.-(carboxy)-4-hydroxybenzyl]-3.beta.-aminoazetidin-2-one. The 3.beta.Type: GrantFiled: August 15, 1978Date of Patent: December 25, 1979Assignee: Eli Lilly and CompanyInventors: Robin D. G. Cooper, Gary A. Koppel, Lawrence J. McShane
-
Patent number: 4158004Abstract: Process for 1-[.alpha.-(carboxy)-4-hydroxy or protected-hydroxybenzyl]-3-acylamidoazetidin-2-one esters, useful intermediates for preparing antibiotic FR 1923, comprising the ring opening of a 2-acyl-3,3-dialkyl-7-oxo-.alpha.-[4-(protected-hydroxyphenyl]-4-thia-2,6-d iazabicyclo[3.2.0]heptane-6-acetic acid, ester sulfoxide with a sulfonic acid and heat to provide a 3-acylamido-4-(2-oxaalkylthio)azetidin-2-one ester which on treatment with sulfuryl chloride affords a reaction product mixture that is then reduced with an organo tin hydride, e.g., tri(n-butyl)tin hydride, to the product. N-Deacylation of the 3-acylamido group followed by acylation with the 3-acyl portion of FR 1923, deblocking of the amino-protecting group and deesterification affords FR 1923.Type: GrantFiled: November 5, 1976Date of Patent: June 12, 1979Assignee: Eli Lilly and CompanyInventors: Gary A. Koppel, Robin D. G. Cooper
-
Patent number: 4144232Abstract: Monocyclic .beta.-lactam antibiotics of the formula ##STR1## WHEREIN R is amino or acylamino, e.g., phenylacetylamino, phenylglycylamino and 2-[4-(3-amino-3-carboxypropoxy)phenyl]-2-hydroximinoacetylamino; R.sub.1 is H or ester forming group; R.sub.2 is H, --OCH.sub.3, --SCH.sub.3, or --CH.sub.3 ; and R.sub.3 is H or acetoxy; are useful antibacterials for controlling .beta.-lactamase producing gram-negative bacteria and other pathogens. Intermediates useful in the preparation of the antibiotics and a novel process for preparing 4.alpha.-acetoxy substituted azetidin-2-ones are provided.Type: GrantFiled: November 30, 1977Date of Patent: March 13, 1979Assignee: Eli Lilly and CompanyInventors: Gary A. Koppel, Robin D. G. Cooper
-
Patent number: 4127568Abstract: 1-[.alpha.-(Carboxy)-4-hydroxybenzyl]-3.beta.-aminoazetidin-2-one esters are prepared by converting 2-acyl-3,3-dialkyl-7-oxo-.alpha.-[4-(benzyloxy)phenyl]-4-thia-2,6-diazabic yclo[3.2.0]-heptane-6-acetic acid esters with mercuric acetate in an aqueous organic solvent mixture, e.g., in aqueous methanol, to 7-oxo-3-phenyl-.alpha.-[4-(benzyloxy)phenyl]-4-oxa-2,6-diazabicyclo[3.2.0] hept-2-ene-1-acetic acid esters and the latter are reacted with PCl.sub.5 and pyridine to provide the monocyclic 1-[.alpha.-(carboxy)-4-benzyloxybenzyl]-3.beta.-(.alpha.-chlorobenzylidene amino)-4-chloroazetidin-2-one esters. Reduction of the dichloro azetidin-2-one with an organo tin hydride and azobisisobutyronitrile affords the deschloro, 1-[.alpha.-(carboxy)-4-benzyloxybenzyl]-3.beta.-benzylideneaminoazetidin-2 -one ester. The latter is hydrolyzed and the 4-benzyloxy group is cleaved via catalytic hydrogenolysis to yield an ester of 1-[.alpha.-(carboxy)-4-hydroxybenzyl]-3.beta.-aminoazetidin-2-one. The 3.beta.Type: GrantFiled: March 7, 1977Date of Patent: November 28, 1978Assignee: Eli Lilly and CompanyInventors: Robin D. G. Cooper, Gary A. Koppel, Lawrence J. McShane
-
Patent number: 4048160Abstract: 7-Alkoxy-3-bromomethyl-3-cephems are provided by reacting a 3-methylenecepham with an alkali metal salt of a lower primary alcohol in the presence of a positive brominating agent at a temperature ranging from about -80.degree. to about 0.degree. C. The 3-bromomethylcephems provided by this invention are useful intermediates for the preparation of known cephalosporin antibiotics.Type: GrantFiled: March 22, 1976Date of Patent: September 13, 1977Assignee: Eli Lilly and CompanyInventor: Gary A. Koppel
-
Patent number: 4048163Abstract: 7-Alkoxy-3-chloromethyl-3-cephems are provided by reacting a 3-methylenecepham with an alkali metal salt of a lower primary alcohol in the presence of tert-butyl hypochlorite at a temperature ranging from about -80.degree. to about 0.degree. C. The 3-chloromethylcephems provided by this invention are useful intermediates for the preparation of known cephalosporin antibiotics.Type: GrantFiled: March 22, 1976Date of Patent: September 13, 1977Assignee: Eli Lilly and CompanyInventor: Gary A. Koppel
-
Patent number: 4045435Abstract: Reaction of 3-hydroxy cephalosporins with alkylfluorosulfonates in the presence of a base provides 3-alkoxy cephalosporins which are useful as intermediates for cephalosporin antibiotic preparation.Type: GrantFiled: October 9, 1974Date of Patent: August 30, 1977Assignee: Eli Lilly and CompanyInventor: Gary A. Koppel
-
Patent number: 4044000Abstract: 6-Alkoxylated-6-acylamidopenicillanic acids and 7-alkoxylated-7-acylamidocephalosporin acids and esters thereof, are provided by reacting a 6-acylamidopenicillanic acid ester or a 7-acylamidocephalosporin ester under anhydrous conditions at -90.degree. C. to -15.degree. C. with an alkali metal salt of a lower alkyl alcohol in the presence of an excess of the corresponding alcohol to produce, in situ, the anionic form of the antibiotic which on halogenation with a positive halogen compound, e.g. t-butyl hypochlorite, yields the compound of the invention. Compounds of the invention, e.g. 6-methoxy-6-phenoxy-acetamidopenicillanic acid and 7-methoxy-7-[2-(2-thienyl)acetamido]cephalosporanic acid are useful antibiotics.Type: GrantFiled: August 23, 1976Date of Patent: August 23, 1977Assignee: Eli Lilly and CompanyInventor: Gary A. Koppel
-
Patent number: 4042585Abstract: 3-Halomethyl-3-cephems are provided by reacting a 3-methylenecepham with an alkali metal salt of a lower alcohol or a bicyclic amidine base in the presence of a positive halogenating agent at a temperature ranging from -80.degree. to about 20.degree. C. The 3-halomethylcephems provided by this invention are useful intermediates for the preparation of known cephalosporin antibiotics.Type: GrantFiled: March 22, 1976Date of Patent: August 16, 1977Assignee: Eli Lilly and CompanyInventor: Gary A. Koppel
-
Patent number: 4038275Abstract: 3-Hydroxymethyl-2-cephems are provided by (1) reacting a 2-halomethylcephem compound with a .gamma.-hydroxycarboxylic acid salt or a .delta.-hydroxycarboxylic acid salt and (2) reacting the novel .gamma. or .delta.-hydroxy esters thereby obtained with a protic acid. The 3-hydroxymethylcephems provided by the process of this invention are useful intermediates for the preparation of known cephalosporin antibiotics.Type: GrantFiled: April 19, 1976Date of Patent: July 26, 1977Assignee: Eli Lilly and CompanyInventors: Gary A. Koppel, Laurence J. Nummy
-
Patent number: 4029651Abstract: A 3-exomethylenecepham sulfoxide ester is reacted with a mixture of a carboxylic acid of the formula ##STR1## and the corresponding anhydride of said carboxylic acid at a temperature of from about 70.degree. C. to about 130.degree. C. to produce the corresponding 3-acyloxymethyl-.DELTA..sup.2 -cephem. This product is useful as an intermediate in the preparation of antibiotically active cephalosporins.Type: GrantFiled: January 19, 1976Date of Patent: June 14, 1977Assignee: Eli Lilly and CompanyInventor: Gary A. Koppel
-
Patent number: 4012410Abstract: 6-acylamido-6-methoxypenicillanic acids are obtained by reacting a 6-acylamidopenicillanic acid with mercuric acetate in methanol to yield a methyl .alpha.-methoxypenicilloate. Esterification of the latter with isobutylene affords the methyl, t-butyl diester of the methoxypenicilloic acid which undergoes selective hydrolysis in base to provide the free .alpha.-carboxylic acid half t-butyl ester of the penicilloic acid. The latter on reaction with dicyclohexylcarbodiimide affords an oxazolone-thiazolidine of the formula ##STR1## WHICH WITH 98% FORMIC ACID PROVIDES A COMPOUND OF THE INVENTION.Type: GrantFiled: April 14, 1975Date of Patent: March 15, 1977Assignee: Eli Lilly and CompanyInventors: Charles W. Ashbrook, Gary V. Kaiser, Gary A. Koppel
-
Patent number: 4008230Abstract: 3-Hydroxycephalosporins are prepared by treating a 3-hydroxy-4-bromo-2-(2-formylthio-4-oxo-3-amido or imido-1-azetidinyl)-2-butenoate ester with mercuric acetate and contacting the resulting reaction mixture with a mercuric ion precipitator.Type: GrantFiled: October 29, 1975Date of Patent: February 15, 1977Assignee: Eli Lilly and CompanyInventor: Gary A. Koppel
-
Patent number: 3994885Abstract: 6-Alkoxylated-6-acylamidopenicillanic acids and 7-alkoxylated-7-acylamidocephalosporin acids and esters thereof, are provided by reacting a 6-acylamidopenicillanic acid ester or a 7-acylamidocephalosporin ester under anhydrous conditions at -90.degree. C. to -15.degree. C. with an alkali metal salt of a lower alkyl alcohol in the presence of an excess of the corresponding alcohol to produce, in situ, the anionic form of the antibiotic which on halogenation with a positive halogen compound, e.g. t-butyl hypochlorite, yields the compound of the invention. Compounds of the invention, e.g. 6-methoxy-6-phenoxyacetamidopenicillanic acid and 7-methoxy-7-[2-(2-thienyl)acetamido]cephalosporanic acid are useful antibiotics.Type: GrantFiled: January 30, 1975Date of Patent: November 30, 1976Assignee: Eli Lilly and CompanyInventor: Gary A. Koppel
-
Patent number: 3992377Abstract: 7-Acylamido-3-cephem-4-carboxylic acid antibiotics directly substituted in the 3-position of the cephem ring system with a sulfur atom bonded to a 5- or 6-membered heterocyclic ring, a lower alkyl group, or a phenyl or substituted phenyl group are prepared with the corresponding 3-halo-3-cephem esters. For example, p-nitrobenzyl 7-[2-(2-thienyl)acetamido]-3-chloro-3-cephem-4-carboxylate reacts with 1-methyl-1H-tetrazol-5-ylthiol to provide p-nitrobenzyl 7-[2-(2-thienyl)acetamido]-3-[(1-methyl-1H-tetrazol-5-yl)thio]-3-cephem-4- carboxylate. The p-nitrobenzyl ester group is removed by catalytic hydrogenolysis to provide the antibiotic carboxylic acid compound. Alternatively, the antibiotics are prepared by reacting a 3-alkylsulfonyloxy, or 3-arylsulfonyloxy-3-cephem, for example, 3-methanesulfonyloxy-3-cephem, or a 3-p-toluenesulfonyloxy-3-cephem with the heterocyclic thiol, the phenyl or substituted phenylthiol, or with the lower alkylthiol.Type: GrantFiled: December 13, 1974Date of Patent: November 16, 1976Assignee: Eli Lilly and CompanyInventors: Robert R. Chauvette, Gary A. Koppel
-
Patent number: 3962232Abstract: 7.beta.-acylamido-7.alpha.-methoxycephalosporin compounds in which the acylamido group has the formula ##SPC1##In which R is carboxy, protected carboxy, phosphono, protected phosphono, sulfo, or protected sulfo. The compounds exhibit antibiotic activity, in particular against Pseudomonas and Serratia type microorganisms.Type: GrantFiled: November 5, 1973Date of Patent: June 8, 1976Assignee: Eli Lilly and CompanyInventor: Gary A. Koppel
-
Patent number: 3953438Abstract: Reaction of 3-hydroxy cephalosporins with alkylfluorosulfonates in the presence of a base provides 3-alkoxy cephalosporins which are useful as intermediates for cephalosporin antibiotic preparation.Type: GrantFiled: October 9, 1974Date of Patent: April 27, 1976Assignee: Eli Lilly and CompanyInventor: Gary A. Koppel